Human B cells appropriately activated by a B cell mitogen are rendered susceptible to human Interleukin 2 (IL-2) as demonstrated with recombinant human IL-2 (rec. h IL-2). They show increased proliferation and drastically enhanced immunoglobulin secretion. Susceptibility to IL-2 is accompanied with the expression of the IL-2 receptor (Tac antigen) on B cells. The data suggest that IL-2 is one of the lymphokines directly involved in the activation of B lymphocytes.
appropriate B cell activator. B cell proliferation was determined by 3H_ thymidine incorporation whereas differentiation was determined as increased immunoglobulin secretion in culture supernatants measured by solid-phase ELISA. In order to rule out an effect of rec. h IL-2 on residual T cells, this population was removed carefully. This was achieved by rosetting human lymphocytes from spleen or peripheral blood by AETtreated sheep erythrocytes followed by lysis of the remaining T cells with two distinct mono clonal (mAb) anti-T cell antibodies (OKT 3, Ortho; Lyt 3, NEN) and rabbit complement. In addition, to exclude minimum contamination by T cells, cultures with low cell concentrations (2.5 X 10 4 B cells per round-bottom microtiter well) were established for both proliferation and Ig secretion. Cytofluorometric analyses revealed no contamination of T cells considering a detection threshold of 1 % (data not shown). More importantly, T cell depletion of the B cell preparation was demonstrated functionally in assays for proliferation and Ig secretion using the T cell mitogenic mAb OKT 3 (see ref. 6) . It is shown that this monoclonal antibody added either directly or in the presence of rec. h IL-2 to T cell depleted B lymphocyte populations failed to induce proliferative responses comparable to those with rec. h IL-2 alone (Table 1) . Control experiments showed that purified T4 cells are only activated under similar conditions in the presence of exogenous accessory cells (Table 2) as reported before (7). The fact that the addition of the same amount of exogenous accessory cells to the enriched B cell population did neither support an activation by Human B cells were prepared as rosette-negative populations from spleen lymphocytes by rosetting with AET -treated sheep erythrocytes followed by complement-mediated cytolysis of residual T cells by OKT3 and Lyt3 combined with depletion of monocytes by plastic dish adherence. 2.5 X 10 4 B cells were cultured in triplicates in 200 III RPMI 1640 (Gib co) supplemented with 10 % FCS. Heat-killed SAC particles (0.001 % v/v) or OKT3 (2.5 ng/ml) were used as first signal and rec. h IL-2 (10 or 50 ng/ml ~ 100 and 500 arbitrary units) as second signal. The functional activity of rec. h IL-2 was determined by standard titrations using the IL-2 dependent T cell line CTLL-2 (kindly provided by Dr. S. Gillis [Seattle, WA, USA]). One unit was arbitrarily defined as the amount of rec. h IL-2 (= 100 pg) which guarantees half maximal proliferation of 2 x 10' CTLL after 24 h. Mean cpm values are given in the Table (3 d culture, 18 h 'H-thymidine incorporation, 1 IlCi per culture). OKT3 nor influence the B cell activation by Staphylococcus A strain Cowan I particles (SAC) again indicates the lack of contaminating T cells and suggests that B cell activation by SAC is accessory cell independent (F. EMMRICH, manuscript in preparation).
The SAC commonly used as polyclonal pre-activators for the determination of human B cell growth and B cell differentiation (8, 9) were prepared as described (10) . As shown in Table 1 , SAC by itself stimulates B cells to proliferate to a certain extent as described recently (8) . The simultaneous addition of rec. h IL-2 resulted in a further substantial increase of 3H_ Table 3 Although the rec. h IL-2 is prepared from E. coli and contains a minute contamination of bacterial lipopolysaccharide (0.27 ng LPS/mg IL-2 as determined in the Limulus assay by Sandoz, Wien, it should be noted that in the human system LPS does not act as a polyclonal B cell activator (11) .
Moreover, the quantities of LPS used for polyclonal activation of mouse B cells differ in some orders of mangitude from possible LPS contaminations in the rec. h IL-2 preparation. LPS preparations (kindly provided by Dr. C.
GALANOS, Freiburg, FRG) showed no direct proliferative effect on human B cells nor did they provide an additional signal after appropriate preactiva-tion (data not shown). Table 3 demonstrates the pronounced promoting effect of rec. h IL-2 for IgG secretion in purified B cells preactivated by SAC, whereas SAC alone, as well as rec. h IL-2 alone, failed to do so. Again, the addition of small amounts of T cells to the B cell culture did not support a comparable IgG secretion (Table 3) . Studies were undertaken to investigate the putative IL-2 receptor on B cells. As shown in Fig. 1 , a monoclonal antibody which has been demonstrated to bind to the human IL-2 receptor on activated T cells (anti-Tac, ref. 12) also stained SAC-activated B cells. In addition, the same anti-Tac antibody could inhibit the transmission of the signal provided by rec. h IL-2 (F. EMMRICH, manuscript in preparation). The combined data, therefore, argue for the expression of similar IL-2 receptors on both Band T cells activated by the appropriate mitogens.
In conclusion, the data presented show clearly that activated human B cells are susceptible for signals provided by rec. h IL-2 and suggest that this lymphokine is involved in the differentiation and proliferation of B lymphocytes. Similar results have also been obtained with the same IL-2 source using antigen or mitogen activated mouse B lymphocytes (H. MOLL et al., manuscript in preparation). Thus, recombinant lymphokine probes appear to be very useful reagents to re examine well-established views concerning lymphokine functions.
